In addition, GRg3 inhibits the abnormal activation of Glut1 and Glut4 in AGS and HGC-27 human gastric cancer cells, alleviating microvascular abnormalities and thus inhibiting gastric precancerous lesion angiogenesis (Xu et al., 2021). Here, TLE3 is linked to gastric cancer.